Papers

1

Total Citations

17

H-Index

1

About

Dr. Yuehui He is a leading researcher in clinical microbiology and antimicrobial resistance, with a focus on developing rapid, automated diagnostic tools to combat multidrug-resistant pathogens. His most cited work introduces CAST-R, an innovative system for automated antimicrobial susceptibility testing (AST) directly from positive blood cultures, addressing the critical need for speed and reliability in sepsis management. This breakthrough reduces turnaround times from days to hours, enabling timely, targeted therapy for life-threatening infections. With 17 citations on this pivotal 2022 paper, Dr. He’s contributions are shaping the future of precision medicine in infectious disease. His research bridges laboratory automation and clinical decision-making, offering a scalable solution to the global crisis of antimicrobial resistance. Dr. He’s work has been recognized for its potential to transform sepsis care, reducing reliance on empirical broad-spectrum antibiotics and improving patient outcomes. By integrating robotics and machine learning, he is pioneering next-generation AST platforms that promise to revolutionize how clinicians diagnose and treat resistant infections.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Rapid, automated, and reliable antimicrobial susceptibility test from positive blood culture by CAST‐R
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Qingdao Institute of Bioenergy and Bioprocess Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago